Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorArriola, Edurne
dc.contributor.authorGonzalez-Cao, Maria
dc.contributor.authorDe Castro, Javier
dc.contributor.authorBernabé, Reyes
dc.contributor.authorNAVARRO, ALEJANDRO
dc.contributor.authorcobo, manuel
dc.contributor.authorDomine, Manuel
dc.date.accessioned2023-06-08T07:29:28Z
dc.date.available2023-06-08T07:29:28Z
dc.date.issued2022-06
dc.identifier.citationArriola E, González-Cao M, Domine M, De Castro J, Cobo M, Bernabé R, et al. Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis. Oncol Ther. 2022 Jun;10:167–84.
dc.identifier.issn2366-1089
dc.identifier.urihttps://hdl.handle.net/11351/9684
dc.descriptionQuimioteràpia; Immunoteràpia; Carcinoma de pulmó de cèl·lules petites
dc.description.sponsorshipThis work was supported by Roche, including the Journal’s Rapid Service Fee.
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofseriesOncology and Therapy;10
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectPulmons - Càncer - Tractament
dc.subjectQuimioteràpia combinada
dc.subjectPulmons - Càncer - Immunoteràpia
dc.subject.meshCarcinoma, Non-Small-Cell Lung
dc.subject.mesh/drug therapy
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.titleAddition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1007/s40487-021-00182-0
dc.subject.decscarcinoma de pulmón de células no pequeñas
dc.subject.decs/farmacoterapia
dc.subject.decsprotocolos de quimioterapia antineoplásica combinada
dc.relation.publishversionhttps://doi.org/10.1007/s40487-021-00182-0
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Arriola E] Medical Oncology Department, Hospital Universitari del Mar-CIBERONC, Barcelona, Spain. [González-Cao M] Medical Oncology Department (IOR), Hospital Dexeus, Barcelona, Spain. [Domine M] Medical Oncology Department, Fundación Jiménez Díaz, Madrid, Spain. [De Castro J] Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain. [Cobo M] Inter-Center Medical Oncology Clinical Management Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain. [Bernabé R] Medical Oncology Department, Hospital Virgen del Rocío, Sevilla, Spain. [Navarro A] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid35032007
dc.identifier.wos000742566400001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple